Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» beta-lactamase inhibitors
beta-lactamase inhibitors
Merck’s Relebactam Met Primary Endpoints in Phase 3 Study
Market Realist
Mon, 04/23/18 - 09:18 am
Merck
relebactam
beta-lactamase inhibitors
clinical trials